Drrx stocktwits

Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. DRRX Stock Price and Chart — NASDAQ:DRRX — TradingView DRRX, 1D PennyStock101 DURECT Corp. is a biopharmaceutical company, which engages in the research, development, and manufacturing of pharmaceutical products. The …

View the basic DRRX option chain and compare options of DURECT Corporation on Yahoo Finance. DRRX Stock | Message Board | Durect Corp. - Investors Hangout DRRX Stock Message Board for Investors. Durect Corp. Stock Price, News and Company Updates. Message Board Total Posts: 42 DRRX - Durect Corp Stock Barchart Opinion - Barchart.com Durect Corp (DRRX) [[ item.lastPrice ]] [[ item.priceChange ]] Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. The Opinions takes up to 5 years' worth of historical data and runs these prices through thirteen different technical indicators. After each

OMI Stock Price | Owens & Minor Inc. Stock ... - MarketWatch

DRRX Stock Price | Durect Corp. Stock Quote ... - MarketWatch DRRX | Complete Durect Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. DURECT Corporation (DRRX) Stock Price, Quote, History ... DURECT Corporation (Nasdaq: DRRX) today announced that it will report its fourth quarter and year ended December 31, 2019 financial results and host a conference call after the market close on DRRX Pre-Market Quotes - Nasdaq Stock Market | Stock ... DURECT Corporation Common Stock (DRRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

DURECT Corporation Common Stock (DRRX) Stock Quotes | Nasdaq

DRRX | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for DURECT CORP (DRRX), including profile, stock chart, recent news and events, analyst opinions, and research reports. StockTwits Read live tweets from the financial and investing community about the stock you're interested in. DRRX | Durect Corp. Analyst Estimates | MarketWatch Nov 10, 2019 · Durect Corp. analyst estimates by MarketWatch. View DRRX revenue estimates and earnings estimates, as well as analyst recommendations. $DRRX Stock Technical Analysis | DURECT | SwingTradeBot.com Nov 04, 2019 · DRRX on StockCharts.com DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms. It focuses on the development of products for the treatment of various chronic and episodic disease areas, such as pain, central nervous system disorders, cardiovascular disease, and other … DURECT Corporation (DRRX) Company Profile & Facts - Yahoo ...

Nov 10, 2019 · Durect Corp. analyst estimates by MarketWatch. View DRRX revenue estimates and earnings estimates, as well as analyst recommendations.

Progenics Pharmaceuticals Inc. (PGNX) Stock Forum ... Find the latest Progenics Pharmaceuticals Inc. (PGNX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. DRRX News Today (DURECT) | MarketBeat View breaking news headlines for DRRX stock from trusted media outlets at MarketBeat. What's going on at DURECT (NASDAQ:DRRX)? View breaking news headlines for DRRX stock from trusted media outlets at MarketBeat. Sign up Log in . Share on Stocktwits. Print this article. Share by Email. Headlines DURECT (NASDAQ DRRX) News Headlines.

DURECT Corporation (DRRX) Options Chain - Yahoo Finance

Mar 25, 2020 · durect corp (drrx): * durect corp (drrx) - on dec 31, 2019, co, oxford finance llc entered into a third amendment of $20.0 million loan and security agreement. * durect corp (drrx) - third amendment modified terms of loan agreement to extend first principal … FDA Nod For MRK's Antibiotic; DRRX Awaits Big Day In Dec ... Jul 18, 2019 · DRRX closed Wednesday's trading at $0.69, up 0.83%. The FDA has given market clearance for FX 635 Laser system, developed by privately-held Erchonia Corporation, for chronic low back pain of

$DRRX Stock Technical Analysis | DURECT | SwingTradeBot.com DRRX closed down 14.35 percent on Wednesday, March 18, 2020, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. DURECT Corporation DURECT Corporation Announces Fourth Quarter and Full Year 2019 Financial Results and Update of Programs. March 3, 2020. DURECT Corporation to Announce 2019 Financial Results on March 3. February 26, 2020. DURECT Corporation Announces Outcome of FDA Advisory Committee Meeting for POSIMIR® January 17, 2020